tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BLTE Stock Latest News

Needham healthcare analysts hold analyst/industry conference call
The FlyNeedham healthcare analysts hold analyst/industry conference call
23h ago
JNJ
NVS
Belite Bio, Inc. Appoints New Auditor
PremiumCompany Announcements
Belite Bio, Inc. Appoints New Auditor
6d ago
6K
BLTE
Belite Bio price target raised to $80 from $79 at Benchmark
PremiumThe Fly
Belite Bio price target raised to $80 from $79 at Benchmark
8d ago
BLTE
Belite Bio, Inc. ADR: Promising Clinical Progress and Strong Financial Position Drive Buy Rating
PremiumRatings
Belite Bio, Inc. ADR: Promising Clinical Progress and Strong Financial Position Drive Buy Rating
10d ago
BLTE
Promising Pipeline and Strategic Advancements: Marc Goodman Recommends ‘Buy’ for Belite Bio, Inc.
PremiumRatings
Promising Pipeline and Strategic Advancements: Marc Goodman Recommends ‘Buy’ for Belite Bio, Inc.
15d ago
BLTE
Belite Bio’s Earnings Call: Cautious Optimism Amid Progress
PremiumCompany AnnouncementsBelite Bio’s Earnings Call: Cautious Optimism Amid Progress
16d ago
BLTE
Belite Bio Announces 2025 Annual Shareholder Meeting
Premium
Company Announcements
Belite Bio Announces 2025 Annual Shareholder Meeting
16d ago
6K
BLTE
Positive Buy Rating for Belite Bio, Inc. Driven by Promising Phase 3 DRAGON Trial Results and Regulatory Prospects
Premium
Ratings
Positive Buy Rating for Belite Bio, Inc. Driven by Promising Phase 3 DRAGON Trial Results and Regulatory Prospects
16d ago
BLTE
Belite Bio Advances in Retinal Disease Trials and Financial Position
PremiumCompany Announcements
Belite Bio Advances in Retinal Disease Trials and Financial Position
16d ago
BLTE
PepsiCo to acquire poppi, Guess receives WHP offer: Morning Buzz
PremiumThe Fly
PepsiCo to acquire poppi, Guess receives WHP offer: Morning Buzz
17d ago
X
TM
Morning Movers: Guess jumps following take-private offer
PremiumThe Fly
Morning Movers: Guess jumps following take-private offer
17d ago
TE
CTM
Belite Bio Reports 2024 Financial Results and Clinical Progress
PremiumCompany Announcements
Belite Bio Reports 2024 Financial Results and Clinical Progress
17d ago
6K
BLTE
Belite Bio Releases 2024 Annual Report on Website
PremiumCompany AnnouncementsBelite Bio Releases 2024 Annual Report on Website
17d ago
6K
BLTE
Belite Bio reports Q4 EPS (32c), consensus (31c)
Premium
The Fly
Belite Bio reports Q4 EPS (32c), consensus (31c)
17d ago
BLTE
Belite Bio, Inc. ADR (BLTE) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Belite Bio, Inc. ADR (BLTE) Q4 Earnings Cheat Sheet
19d ago
BLTE
Optimistic Buy Rating for Belite Bio, Inc. Amid Promising DRAGON Trial Results
PremiumRatings
Optimistic Buy Rating for Belite Bio, Inc. Amid Promising DRAGON Trial Results
1M ago
BLTE
Promising Phase 3 Results for Belite Bio’s Tinlarebant in Stargardt Disease Boost Buy Rating
PremiumRatings
Promising Phase 3 Results for Belite Bio’s Tinlarebant in Stargardt Disease Boost Buy Rating
1M ago
BLTE
Belite Bio’s Phase 3 Trial for Stargardt Disease Drug Advances
PremiumCompany Announcements
Belite Bio’s Phase 3 Trial for Stargardt Disease Drug Advances
1M ago
6K
BLTE
Belite Bio announces interim results from DRAGON trial
PremiumThe Fly
Belite Bio announces interim results from DRAGON trial
1M ago
BLTE
Belite Bio Announces $15 Million Direct Offering to Enhance Financial Position
PremiumCompany AnnouncementsBelite Bio Announces $15 Million Direct Offering to Enhance Financial Position
2M ago
6K
BLTE
Belite Bio to sell 258,309 shares at $58.07 in registered direct offering
Premium
The Fly
Belite Bio to sell 258,309 shares at $58.07 in registered direct offering
2M ago
BLTE
Belite Bio files automatic mixed securities shelf
Premium
The Fly
Belite Bio files automatic mixed securities shelf
2M ago
BLTE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >